Article Details

Biohaven Pharmaceutical (NYSE:BHVN) Receives “Buy” Rating from Piper Jaffray Companies

Retrieved on: 2018-12-17 13:26:15

Tags for this article:

Click the tags to see associated articles and topics

Biohaven Pharmaceutical (NYSE:BHVN) Receives “Buy” Rating from Piper Jaffray Companies. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc purchased a new position in Biohaven Pharmaceutical during the third quarter worth approximately $4,996,000. Finally ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo